Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05239338 · ClinicalTrials.gov registry record
Preserving Fertility After Colorectal Cancer Study
A clinical trial of Colorectal Cancer, sponsored by Andreana Holowatyj, PhD, MSCI.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT05239338: Recruiting study of Colorectal Cancer, sponsored by Andreana Holowatyj, PhD, MSCI.
NCT05239338 is a study of Colorectal Cancer that is actively recruiting participants, run by Andreana Holowatyj, PhD, MSCI. The registered enrollment target is 1,000 participants, below the 1,508-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05239338, a study of Colorectal Cancer, is actively recruiting participants, sponsored by Andreana Holowatyj, PhD, MSCI.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The PREFACE Study is a prospective, longitudinal cohort study of reproductive health and clinical outcomes among individuals diagnosed with colorectal cancer between age 18 to 49 years.
Conditions Studied
Study Locations (1)
Tennessee
- Vanderbilt-Ingram Cancer Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2021-12-06 |
| Est. Completion | 2037-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05239338
The ClinicalTrials.gov registry entry for NCT05239338 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,508-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (34% lower). The listed sponsor is Andreana Holowatyj, PhD, MSCI, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05239338 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05239338 about?
NCT05239338 is a clinical study titled "Preserving Fertility After Colorectal Cancer Study". The PREFACE Study is a prospective, longitudinal cohort study of reproductive health and clinical outcomes among individuals diagnosed with colorectal cancer between age 18 to 49 years.
What is the current status of trial NCT05239338?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2021-12-06. Estimated completion is 2037-12.
What conditions does trial NCT05239338 study?
This clinical trial studies the following conditions: Colorectal Cancer.
Who is sponsoring clinical trial NCT05239338?
This trial is sponsored by Andreana Holowatyj, PhD, MSCI, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05239338 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.